CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia2023 · 3 citations
2. 2Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML2020 · 671 citations
3. 3CCAAT/Enhancer Binding Protein α (C/EBPα) and C/EBPα Myeloid Oncoproteins Induce Bcl-2 via Interaction of Their Basic Regions with Nuclear Factor-κB p502005 · 53 citations
4. 4Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia2023 · 5 citations
5. 5Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity2010 · 391 citations